PetMed Express Financials - Benzinga

PetMed Express Inc

PETSNASDAQ

Trade with Public

Trade with Public

$1.76

0.010.57%

At close: Aug 25, 5:00 PM EST

$1.75

-0.0061-0.35%

After Hours: 7:07 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Dividends Compare Options Stock Report

PetMed Express Financials

PetMed Express (PETS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
PetMed Express Q1 EPS $(0.28) Misses $0.12 Estimate, Sales $41.015M Beat $10.336M Estimate

PetMed Express (NASDAQ:PETS) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $0.12 by 333.33 percent. This is a 83.03 percent increase over losses of $(1.65) per share from

Benzinga Newsdesk

PRO
UPDATE: PetMed Express Q4 EPS $(0.19) Up From $(0.56) YoY, Sales $42.817M Down From $50.760M YoY

Benzinga Newsdesk

PRO
PetMed Express Sees Prelim. Q2 Net Sales $43.4M-$44.5M vs $58M In Prior Year Period

Benzinga Newsdesk

PRO
PetMed Express Sees Q4 Net Sales Of $51.1M-$53.1M And Net Loss Of $9.9M-$10.4M; Sees FY25 Net Sales Of $231.6M-$233.6M With Net Loss Of $4.5M-$5.0M

Preliminary Fourth Quarter and FY 2025 Results:For the fiscal fourth quarter ended March 31, 2025, net sales are estimated to range from $51.1 million to $53.1 million compared to $66.5 million in the prior year period.

Benzinga Newsdesk

Earnings Scheduled For June 16, 2025

Benzinga Insights

Earnings Preview: PetMed Express

Benzinga Insights